Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients
Clinical trial NCT00259129 · COMPLETED
Trial details
- NCT number
- NCT00259129
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-02-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.